Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories Ltd has made a disclosure to the stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, along with SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155. This regulation requires listed companies to inform exchanges about material events or developments that may impact investors. The full details of the specific event being disclosed are not visible in the provided headline, as the text appears truncated. Investors should refer to the complete filing on the BSE portal for full context.
By itself, a Regulation 30 compliance filing is a routine disclosure obligation and does not indicate any positive or negative event. Shareholders should check the full announcement for the actual content before drawing any conclusions about stock price impact.